This article is from: srnnews.com
(Reuters) -Sun Pharmaceutical Industries, India’s largest drugmaker by revenue, reported a higher adjusted profit on Thursday, aided by strong sales in the domestic market.
The Mumbai-based firm’s consolidated profit before tax and exception items rose 16.6% to 39.91 billion rupees ($455.6 million) in the quarter ended June 30.
($1 = 87.6000 Indian rupees)
(Reporting by Rishika Sadam; Editing by Sonia Cheema)
Brought to you by www.srnnews.com
